David Chang
Director Técnico/Científico/I+D en CABALETTA BIO, INC. .
Fortuna: - $ al 31/05/2024
Origen de la red de primer grado David Chang.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
123
| Public Company | Pharmaceuticals: Major | 123 |
| Public Company | Biotechnology | 15 | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a David Chang a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chairman Independent Dir/Board Member Director/Board Member Director of Finance/CFO Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Director of Finance/CFO Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Director/Board Member Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member President Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Compliance Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| DIAGEO PLC | Beverages: Alcoholic | Director/Board Member Director/Board Member Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| MIT Sloan School of Management | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
The Institute of International Finance, Inc.
 The Institute of International Finance, Inc. Miscellaneous Commercial ServicesCommercial Services The Institute of International Finance, Inc. operates as a financial institute. The company's members include commercial and investment banks, insurance companies, and investment management firms. It provides stocks, bonds, mutual & financial funds, and other investments services. The company was founded in 1983 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Founder Corporate Officer/Principal | |
European Financial Services Round Table
 European Financial Services Round Table Miscellaneous Commercial ServicesCommercial Services European Financial Services Round Table operates as an association to regulate the financial risks. It specializes in bringing together chairman and chief executives of European banks and insurance companies. The purpose of the EFR is to contribute to the European public policy debate on issues relating to financial services and to the financial stability with the completion of the single market in financial services. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VODAFONE GROUP PLC | Wireless Telecommunications | Chief Executive Officer Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Amsterdam | College/University | Graduate Degree Corporate Officer/Principal | |
| University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
| BG GROUP | Contract Drilling | Chairman Director of Finance/CFO | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President Private Equity Investor | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Wake Forest University | College/University | Director/Board Member Doctorate Degree | |
| SHATTUCK LABS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| PURETECH HEALTH PLC | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| BP PLC | Integrated Oil | Director/Board Member Director/Board Member | |
| Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Director/Board Member | |
| DEUTSCHE BANK AG | Investment Banks/Brokers | Director/Board Member Corporate Officer/Principal | |
| University of Durham | College/University | Undergraduate Degree Undergraduate Degree | |
The Financial Reporting Council Ltd.
 The Financial Reporting Council Ltd. Miscellaneous Commercial ServicesCommercial Services The Financial Reporting Council Ltd. is a regulatory body that oversees auditors, accountants, and actuaries. The non-profit company is based in London, UK. The British company is responsible for setting the Corporate Governance and Stewardship Codes and promoting transparency and integrity in business. The company's work is aimed at investors and others who rely on company reports, audit, and high-quality risk management. The CEO of the company is Sarah Rapson. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Imperial College London | College/University | Corporate Officer/Principal Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 25 |
| Reino Unido | 18 |
| Francia | 3 |
| Bélgica | 2 |
| Irlanda | 2 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 16 |
| Finance | 5 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Operativa
| Director/Board Member | 499 |
| Corporate Officer/Principal | 273 |
| Independent Dir/Board Member | 165 |
| Chairman | 119 |
| Chief Executive Officer | 79 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Anjali Bansal | 37 |
| Christopher Viehbacher | 37 |
| Tom de Swaan | 35 |
| James Murdoch | 32 |
| Simon Dingemans | 31 |
| Urs Rohner | 30 |
| Lynn Elsenhans | 28 |
| Jean-Pierre Garnier | 28 |
| Catherine Sohn | 27 |
| Shah Hussain | 25 |
| Philip Hampton | 24 |
| Gerardus Johannes Wijers | 23 |
| Shawn Tomasello | 22 |
| H. Culp | 21 |
| Michael Owen | 20 |
- Bolsa de valores
- Insiders
- David Chang
- Conexiones Empresas
